Background illustration for clinical trials search

Paid Clinical Trials Sheboygan

Discover 661 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Milwaukee WI, Glenview IL, Chicago IL, Naperville IL,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting

Web-based Physical Activity Program

for
Physical Activity
Location: Milwaukee WI
Sponsor: Karnes, Sasha

Sex: All

Age: 21 - 55

Code: NCT01218412

Phase1, Recruiting
New

Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure

for
Healthy Adult Participants
Location: Milwaukee WI, Chicago IL, Detroit MI, Indianapolis IN,
Sponsor: Ecotera Health LLC

Sex: All

Age: 18+

Code: NCT07775495

Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for
Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Location: Milwaukee WI, Madison WI, Lansing MI, Ypsilanti MI,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT00271180

Recruiting

Online-Delivered Comprehensive Behavioral Intervention for Tics-Enhanced (CBIT-E)

for
Persistent Tic Disorders, Tourette Disorder
Location: Milwaukee WI
Sponsor: Marquette University

Sex: All

Age: 9 - 17

Code: NCT05050734

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

for
Persistent Corneal Epithelial Defect
Location: Milwaukee WI, Madison WI, Fraser MI, Carmel IN,
Sponsor: Glaukos Corporation

Sex: All

Age: 2+

Code: NCT05966493

Phase2, Recruiting

PEN-866 in Patients With Advanced Solid Malignancies

for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Milwaukee WI, Detroit MI, Omaha NE, Nashville TN,
Sponsor: Tarveda Therapeutics

Sex: All

Age: 18+

Code: NCT03221400

Phase1, Phase2, Recruiting

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

for
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 2 - 18

Code: NCT00036712

Phase2, Recruiting

SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease

for
Peripheral Arterial Disease
Location: Milwauke WI, Chicago IL, Rochester MN, Detroit MI,
Sponsor: Juventas Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT02544204

Phase2, Recruiting

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

for
Brain and Central Nervous System Tumors, Metastatic Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70

Code: NCT00002647

Phase1, Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia,
Location: Milwaukee WI, Minneapolis MN, Baltimore MD, Atlanta GA,
Sponsor: Imugene Limited

Sex: All

Age: 18+

Code: NCT03666000

Phase1, Recruiting

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

for
Sarcoma
Location: Milwaukee WI, Green Bay WI, Grand Rapids MI, Chicago IL,
Sponsor: University of Leicester

Sex: All

Age: 0 - 49

Code: NCT00020566

Phase3, Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Milwaukee WI, Grand Rapids MI, Chicago IL, Aurora IL,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: Milwaukee WI, Grand Rapids MI, Chicago IL, Aurora IL,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Milwaukee WI, Chicago IL, Aurora IL, Ann Arbor MI,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

Platform Clinical Study for Conquering Scleroderma

for
Interstitial Lung Disease Due to Systemic Disease, Scleroderma
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Rochester MN,
Sponsor: Scleroderma Research Foundation, Inc.

Sex: All

Age: 18+

Code: NCT06195072

Phase2, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Milwaukee WI, Gurnee IL, Glenview IL, Des Plaines IL,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase3, Recruiting

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

for
Aortic Stenosis
Location: Milwaukee WI, Grand Rapids MI, Fort Wayne IN,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18 - 70+

Code: NCT06777368

Recruiting

ELEVATE-HFpEF Clinical Study

for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Milwaukee WI, Chicago IL, Minneapolis MN, Columbus OH,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Sex: All

Age: 40+

Code: NCT06678841

Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

for
Heart Failure
Location: Milwaukee WI, Merrillville IN, Peoria IL,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06033950

Phase3, Recruiting